Observational study for personalized cancer therapy at Medical College of Wisconsin
Medical College of Wisconsin Master Predict (Profile Related Evidence Determining Individualized Cancer)
This study is collecting and analyzing samples from cancer patients at the Medical College of Wisconsin to see how personalized treatments can improve care while making the process easier for everyone involved.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical College of Wisconsin Academic / other |
| Locations | 1 site (Milwaukee, Wisconsin) |
| Trial ID | NCT05802069 on ClinicalTrials.gov |
What this trial studies
This observational study collects and analyzes data from patients undergoing cancer-related interventions at the Medical College of Wisconsin Cancer Center. It utilizes both retrospective and prospective data collection methods, allowing for the analysis of biospecimens and the application of advanced technologies like machine learning. The goal is to facilitate multiple minimal-risk studies under a master protocol, thereby reducing the burden on patients and researchers. Participants may consent to the collection of blood, stool, and urine samples for further research-related testing.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are currently receiving or have previously received care for a cancer-related condition at the Medical College of Wisconsin.
Not a fit: Patients who are not receiving cancer-related care or are under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective cancer therapies for patients.
How similar studies have performed: Other studies utilizing similar observational and biospecimen collection approaches have shown promise in advancing cancer research and treatment personalization.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects aged 18 years and older who were previously or are currently receiving care for a cancer-related condition at MCW/FH.
Where this trial is running
Milwaukee, Wisconsin
- Froedtert Hospital and the Medical College of Wisconsin — Milwaukee, Wisconsin, United States (Recruiting)
Study contacts
- Principal investigator: Sameem Abedin, MD — Medical College of Wisconsin
- Study coordinator: Kristina Jacobs
- Email: kjacobs@mcw.edu
- Phone: 414-955-3643
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.